Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  5,247 results for ""Factor Xa""

Your Filters

Subject : atrial fibrillation
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Coagulation Factor Xa Has No Effects on the Expression of PAR1, PAR2, and PAR4 and No Proinflammatory Effects on HL-1 Cells.

  • Authors : Ruf L; Institute of Clinical Chemistry and Pathobiochemistry, Department of Pathobiochemistry, Otto-von-Guericke-University Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany.; Bukowska A

Subjects: Atrial Fibrillation* ; Factor Xa*/Factor Xa*/Factor Xa*/metabolism; Animals

  • Source: Cells [Cells] 2023 Dec 15; Vol. 12 (24). Date of Electronic Publication: 2023 Dec 15.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

Read More Add to Saved list
×
Editorial & Opinion

Prothrombin Complex Concentrate or Coagulation Factor Xa (Recombinant), Inactivated-zhzo.

  • Authors : Peled H; In-Patient Cardiology/Non-invasive Lab and Critical Care, St. Jude Medical Center, Fullerton, CA. Electronic address: .; Dau NQ

Subjects: Atrial Fibrillation* ; Factor Xa*; Blood Coagulation Factors

  • Source: Chest [Chest] 2019 Jun; Vol. 155 (6), pp. 1308.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Internet ISSN: 1931-3543

Record details

Read More Add to Saved list
×
Academic Journal

Anti-Xa activity in oral factor Xa inhibitor-treated patients with atrial fibrillation and a higher risk of bleeding: a pilot study.

  • Authors : Samoš M; Department of Internal Medicine I, Jessenius Faculty of Medicine in Martin.; Bolek T

Subjects: Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*drug therapy ; Factor Xa/Factor Xa/Factor Xa/*drug effects ; Factor Xa Inhibitors/Factor Xa Inhibitors/Factor Xa Inhibitors/*pharmacology

  • Source: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2018 Jun; Vol. 29 (4), pp. 369-373.Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9102551 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial.

  • Authors : Eisen A; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, MA.; Giugliano RP

Subjects: United States Food and Drug Administration*; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*complications ; Factor Xa/Factor Xa/Factor Xa/*drug effects

  • Source: American heart journal [Am Heart J] 2016 Feb; Vol. 172, pp. 144-51. Date of Electronic Publication: 2015 Dec 01.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Record details

Read More Add to Saved list
×
Academic Journal

Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial.

Subjects: Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*complications ; Embolism/Embolism/Embolism/*prevention & control ; Factor Xa/Factor Xa/Factor Xa/*therapeutic use

  • Source: American heart journal [Am Heart J] 2015 Oct; Vol. 170 (4), pp. 669-74. Date of Electronic Publication: 2015 Jul 02.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Record details

Read More Add to Saved list
×
Academic Journal

Distribution of anti‐factor Xa activity in patients with nonvalvular atrial fibrillation receiving 15 mg dose of edoxaban.

Subjects: ANTICOAGULANTS; LOW-molecular-weight heparin; T-test (Statistics)JAPAN

  • Source: Journal of Arrhythmia; Oct2024, Vol. 40 Issue 5, p1126-1130, 5p

Record details

Read More Add to Saved list
×
Academic Journal

Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation.

  • Authors : Galanis T; Thomas Jefferson University Hospitals, Philadelphia, PA, USA.; Merli GJ

Subjects: Antithrombins/Antithrombins/Antithrombins/*therapeutic use ; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*complications ; Factor Xa/Factor Xa/Factor Xa/*therapeutic use

  • Source: Hospital practice (1995) [Hosp Pract (1995)] 2013 Feb; Vol. 41 (1), pp. 26-36.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101268948 Publication Model: Print Cited Medium: Print ISSN: 2154-8331

Record details

Read More Add to Saved list
×
Academic Journal

Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.

  • Authors : Spronk HM; Laboratory for Clinical Thrombosis and Haemostasis, Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, PO Box 616, UNS50 Box 8, 6200 MD Maastricht, The Netherlands.; de Jong AM

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use ; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*drug therapy ; Blood Coagulation/Blood Coagulation/Blood Coagulation/*drug effects

  • Source: Cardiovascular research [Cardiovasc Res] 2014 Mar 01; Vol. 101 (3), pp. 344-51. Date of Electronic Publication: 2014 Jan 02.Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Evaluation of oral anticoagulation with rivaroxaban, in patients with new onset non valvular atrial fibrillation].

  • Authors : Neira V; División de Enfermedades Cardiovasculares, Pontificia Universidad Católica de Chile, Santiago, Chile.; Corbalán R

Subjects: Antithrombin III/Antithrombin III/Antithrombin III/*drug effects ; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*blood ; Factor Xa/Factor Xa/Factor Xa/*drug effects

  • Source: Revista medica de Chile [Rev Med Chil] 2016 Sep; Vol. 144 (9), pp. 1103-1111.Publisher: Sociedad Médica de Santiago Country of Publication: Chile NLM ID: 0404312 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts".

Subjects: Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*drug therapy ; Embolism/Embolism/Embolism/*prevention & control ; Factor Xa/Factor Xa/Factor Xa/*adverse effects

  • Source: Circulation [Circulation] 2013 Sep 10; Vol. 128 (11), pp. e172-3.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  5,247 results for ""Factor Xa""